Dalotuzumab
id:
dalotuzumab-194-17887283
title:
Dalotuzumab
text:
Dalotuzumab is an anti-IGF1 receptor (IGF1R) humanized monoclonal antibody designed for the potential treatment of various cancers. Common adverse effects include hyperglycemia, nausea, vomiting, and fatigue. Dalotuzumab was developed by Merck and Co., Inc.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dalotuzumab
date created:
date modified:
2023-12-20T19:48:32Z
main entity:
{"identifier":"Q5211586","url":"https://www.wikidata.org/entity/Q5211586"}
image:
fields total:
13
integrity:
14